Literature DB >> 19896738

Gender differences in angiotensin II and aldosterone secretion in patients with pressure overloaded systemic right ventricles are similar to those observed in systemic arterial hypertension.

Piotr Szymański1, Anna Klisiewicz, Barbara Lubiszewska, Magdalena Lipczyńska, Mirosław Kowalski, Jadwiga Janas, Piotr Hoffman.   

Abstract

BACKGROUND: There are very few and inconclusive data concerning the renin-angiotensin-aldosterone system activity in adults with systemic right ventricles, compared to classic heart failure patients. Therefore, we prospectively evaluated angiotensin II and aldosterone levels in a series of patients following Mustard or Senning procedures for complete transposition of the great arteries.
METHODS: Forty-two patients (31 male and 11 female, mean age 20.8 ± 3.7 years), 18.2 ± 2.8 years following atrial switch procedures, were included in the analysis. All the patients underwent comprehensive echocardiographic examinations. Angiotensin II and aldosterone levels were measured with immunoradiometric assays.
RESULTS: The mean angiotensin II level was 11.9 ± 9.4 pg/mL; 15 patients (35.7%) had angiotensin II levels exceeding the upper limit of normal values. There was a negative correlation between angiotensin II levels and treatment with angiotensin enzyme inhibitors (r = -0.33, P = 0.03). The mean aldosterone level was 217.7 ± 160.2 pg/mL; 26 patients (61.9%) had aldosterone levels exceeding the upper limit of normal values. Female patients had significantly higher aldosterone levels than male patients (321 ± 248 vs 180 ± 95 pg/mL, P = 0.01). A negative correlation between angiotensin II levels and fractional area change (r = -0.65, P=0.03), and a positive correlation between aldosterone levels and right ventricular end-diastolic area (r = 0.66, P = 0.03) were observed in female but not in male patients.
CONCLUSIONS: Renin-angiotensin-aldosterone axis activation in patients with systemic right ventricles was similar to reported values in other studies of stable heart failure. The gender differences in aldosterone levels in patients with systemic right ventricles were similar to that associated with left ventricular remodeling in systemic arterial hypertension.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896738     DOI: 10.1016/j.ijcard.2009.09.535

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease.

Authors:  M Elizabeth Moss; Brigett Carvajal; Iris Z Jaffe
Journal:  Pharmacol Ther       Date:  2019-07-02       Impact factor: 12.310

Review 2.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

3.  Does gender affect the association between right ventricular strain and arterial hypertension?

Authors:  Marijana Tadic; Cesare Cuspidi; Branislava Ivanovic; Biljana Pencic; Guido Grassi; Vera Celic
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-09       Impact factor: 3.738

4.  Gender differences and the association between right ventricular strain and arterial hypertension-A commentary.

Authors:  Piotr Szymański; Magdalena Lipczyńska
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-08       Impact factor: 3.738

5.  Response to: Gender differences and the association between right ventricular strain and arterial hypertension-A commentary.

Authors:  Marijana Tadic; Cesare Cuspidi; Branislava Ivanovic; Biljana Pencic; Guido Grassi; Vera Celic
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-11-08       Impact factor: 3.738

6.  Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation.

Authors:  Nathanne S Ferreira; Stêfany B A Cau; Marcondes A B Silva; Carla P Manzato; Fabíola L A C Mestriner; Takayuki Matsumoto; Fernando S Carneiro; Rita C Tostes
Journal:  Front Pharmacol       Date:  2015-03-02       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.